Document ID: chunk:federal_register_of_legislation:F2024C00874:clause:2_9:p2
Version: federal_register_of_legislation:F2024C00874
Segment Type: clause
Provision Reference: sch 2 cl 9 (pt 2/2)
Character Range: 12885–14536

relocated
Div = Division(s)                               renum = renumbered
exp = expires/expired or ceases/ceased to have  rep = repealed
effect                                          rs = repealed and substituted
F = Federal Register of Legislation             s = section(s)/subsection(s)
gaz = gazette                                   Sch = Schedule(s)
LA = Legislation Act 2003                       Sdiv = Subdivision(s)
LIA = Legislative Instruments Act 2003          SLI = Select Legislative Instrument
(md not incorp) = misdescribed amendment        SR = Statutory Rules
cannot be given effect                          Sub‑Ch = Sub‑Chapter(s)
mod = modified/modification                     SubPt = Subpart(s)
No. = Number(s)                                 underlining = whole or part not
o = order(s)                                    commenced or to be commenced
Ord = Ordinance

Endnote 3—Legislation history

Name                                                                                                 Registration                Commencement  Application, saving and transitional provisions
Therapeutic Goods (Advertising Complaints and Investigations Information) Specification 2019         21 Jan 2019 (F2019L00050)   22 Jan 2019   —

Therapeutic Goods (Advertising Complaints and Investigations Information) Amendment Instrument 2024  27 Sept 2024 (F2024L01229)  28 Sept 2024  —

Endnote 4—Amendment history

Provision affected          How affected
s 2.....................    rep LA s 48D
s 5.....................    rep LA s 48C
Schedule 1................  rep LA s 48C
Schedule 2................  am F2024L01229